Emilio Porfiri

1 - 10 out of 12Page size: 10
Sort by: Start date

Research Projects

  1. A Phase II multicentre trial of PF-03856884 (cvx-060), a selective angiopoietin-2 (ANG- 2) inhibitor in combination with axitinib in patients with previously treated metastatic renal cell carcinoma

    Emilio Porfiri

    UHB NHS TRUST

    1/11/12 → 31/07/13

    Project: Research

  2. Assessing the specificity and improving the usage of novel cancer drugs: a study of the tyrosine phosphorpoteome in tumour tissue and blood samples from patients treated with tyrosine kinase inhibitors

    Emilio Porfiri

    UHB CHARITABLE FUNDS

    22/08/11 → 14/11/13

    Project: Research

  3. Axis Trial: Axitinib (AG-013736) as second line therapy for metastatic renal cell cancer.

    Emilio Porfiri

    UHB NHS TRUST

    1/12/08 → 31/12/17

    Project: Research

  4. (60MTHS)CRUK Clinical Trials Unit, University of Birmingham

    Pamela Kearns, Lucinda Billingham, Sarah Bowden, Charles Craddock, , Nicholas James, Paul Moss, Daniel Palmer, Emilio Porfiri, Daniel Rea & Neil Steven

    Cancer Research UK

    1/10/08 → 30/09/13

    Project: Research

  5. A study of angiogenesis markers in patients with Clear-Cell Renal Cell Carcinoma undergoing therapy with sunitinib: correlations with tumour response and prognosis

    Emilio Porfiri

    PFIZER LIMITED

    22/11/07 → 30/11/10

    Project: Industry

  6. (Joint with 13006) A Randomised Phase III Study of Docetaxel plus Prednisolone vs Docetaxel with Prednisolone plus Either Zoledronic Acid, Strontium-89 or Both Agents Combined

    Nicholas James, Emilio Porfiri, Lucinda Billingham & Guiqing Yao

    NIHR EVALUATION, TRIALS AND STUDIES COORDINATING CENTRE

    1/04/07 → 28/02/13

    Project: Other Government Departments

  7. (Joint with 13512) A Randomised Phase III Study of Docetaxel plus Prednisolone vs Docetaxel with Prednisolone plus Either Zoledronic Acid, Strontium-89 or Both Agents Combined

    Nicholas James, Emilio Porfiri, Pelham Barton & Lucinda Billingham

    NIHR EVALUATION, TRIALS AND STUDIES COORDINATING CENTRE

    1/04/07 → 31/05/18

    Project: Research

  8. A Study of Ad-NTR-GMCSF, Given via Brachytherapy, Followed by CB1954 in Patients with Locally Relapsed Prostate Cancer

    Emilio Porfiri, Nicholas James, Vivien Mautner, Peter Searle, Steve Lee & Lawrence Young

    MEDICAL RESEARCH COUNCIL, NIHR

    19/03/07 → 18/07/15

    Project: Research

  9. Prodrug Activation Gene Therapy for Cancer: Optimising Enzymes, Vectors and Immune Responses

    Peter Searle, Nicholas James, Vivien Mautner, Daniel Palmer, Emilio Porfiri & Lawrence Young

    Cancer Research UK

    1/12/06 → 31/10/09

    Project: Research

  10. A Phase II, Randomised, Double-blind, Parallel Group Study to Assess the Efficacy of AZD2171 45mg Versus Placebo following 12 Weeks of Treatment in Patients with Metastatic or Recurrent Renal Cell Carcinoma who have had no Previous Anti-VE

    Emilio Porfiri

    UHB NHS TRUST

    14/11/06 → 31/07/12

    Project: Research

Previous 1 2 Next